Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
GMO Research&AI, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 4.0 times, Exceeds Full-Year Plan
3695 GMO Product Platform,Inc. 【J-GAAP】
Earnings ReportGMO Product Platform,Inc. <3695> [TSE Growth] announced its financial results after the market closed on November 12th (15:31). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2025 (January to September) surged 4.0 times that of the same period last year, reaching 266 million yen. Progress toward the full-year plan of 173 million yen is 153.8%, already exceeding the target and also exceeding the five-year average of 57.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the October to December period (4Q) is expected to turn into a loss of 93 million yen (compared to a profit of 181 million yen in the same period last year). However, if the fourth-quarter performance remains at the same level as the first three quarters, the full-year plan may be increased.
In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a profit of 177 million yen (compared to a loss of 21 million yen in the previous period). The operating profit margin drastically improved from 0.3% in the same period last year to 10.4%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Sep, 2023 | 3,801 | 303 | 311 | 217 | 133.0 | 72.7 | Nov 6, 2023 | J-GAAP |
| Jan - Sep, 2024 | 3,657 | 73 | 67 | 58 | 35.8 | 27.0 | Nov 6, 2024 | J-GAAP |
| Jan - Sep, 2025 | 4,916 | 295 | 266 | 95 | 27.5 | 153.8 | Nov 12, 2025 | J-GAAP |
| YoY | +34.4% | +304.1% | +297.0% | +63.8% | -23.3% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 2,560 | 165 | 160 | 111 | 68.0 | 114.84 | Feb 12, 2025 | J-GAAP |
| Jul - Dec, 2025 Guidance | 3,485 | 91 | 84 | 20 | 4.5 | 34.58 | Aug 7, 2025 | J-GAAP |
| YoY | +36.1% | -44.8% | -47.5% | -82.0% | -93.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 5,117 | 440 | 428 | 307 | 188.2 | 114.84 | Feb 5, 2024 | J-GAAP |
| Dec, 2024 | 5,025 | 235 | 248 | 183 | 112.1 | 114.84 | Feb 12, 2025 | J-GAAP |
| Dec, 2025 Guidance | 6,654 | 205 | 173 | 9 | 2.0 | 34.58 | Aug 7, 2025 | J-GAAP |
| YoY | +32.4% | -12.8% | -30.2% | -95.1% | -98.2% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 1,192 | 3 | -21 | -14 | -8.7 | 0.3 | Nov 6, 2024 | J-GAAP |
| Oct - Dec, 2024 | 1,368 | 162 | 181 | 125 | 76.6 | 11.8 | Feb 12, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,318 | -89 | -97 | -67 | -41.1 | -6.8 | May 13, 2025 | J-GAAP |
| Apr - Jun, 2025 | 1,851 | 203 | 186 | 56 | 19.3 | 11.0 | Aug 7, 2025 | J-GAAP |
| Jul - Sep, 2025 | 1,747 | 181 | 177 | 106 | 30.7 | 10.4 | Nov 12, 2025 | J-GAAP |
| YoY | +46.6% | +5,933.3% | - | - | - |
Related Articles
GMO Pepabo, Net Income Forecast for the Fiscal Year Revised Upward by 10%, Highest in Five Terms, Dividend Revised Upward by 9 Yen
GMO GlobalSign, Jul-Sep (3Q) Ordinary Profit Increases by 12 times
Solvvy, Jul-Sep (1Q) Ordinary Profit Decreases by 21%
Akatsuki, Jul-Sep (2Q) Ordinary Profit Increases by 10%
GMO Media, Jul-Sep (3Q) Ordinary Profit Increases by 43%
Hokuryo, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 17%, Exceeded Record Profit Forecast, Dividend Revised Upward by 15 Yen
GMO Commerce, Jan-Sep (Cumulative 3Q) Ordinary Profit 394 Million Yen
VIS, First Half Ordinary Profit Decreases by 34%, Jul-Sep Ordinary Profit Decreases by 27%
SORACOM, Jul-Sep (2Q) Ordinary Profit Increases by 2.4 times
ORION BREWERIES, First Half Ordinary Profit 2.6 Billion Yen